AKT1 and breast carcinoma: SGK3 is involved in the resistance to class 1 PI3K or Akt inhibitors in breast cancer as SGK3 can substitute for the loss of Akt activity and restore proliferation (Bago et al., 2016; Tovell et al., 2019b).